Gastroretentive particles formulated with thiomers: Development and in vitro evaluation

Journal of Drug Targeting

Volumn 18, Issue 5, 2010, Pages 362-372

  Senyigit, Zeynep Ay ^a   Vetter, Anja ^b   Guneri, Tamer ^a   Bernkop Schnürch, Andreas ^b  

^a EGE UNIVERSITY   (Turkey)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Gastroretentive drug delivery systems; Particulate delivery systems; Permeation; Riboflavin; Thiomers

Indexed keywords

AMIDINE; CHITOSAN 4 THIOBUTHYLAMIDINE; CYSTEINE; POLYACRYLIC ACID; RIBOFLAVIN 5' MONOPHOSPHATE SODIUM DIHYDRATE; SODIUM DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; ATMOSPHERIC PRESSURE; CONTROLLED STUDY; COVALENT BOND; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG FORMULATION; DRUG PENETRATION; DRUG SYNTHESIS; EMULSION; IN VITRO STUDY; MEAN RESIDENCE TIME; MUCOADHESION; NONHUMAN; OXIDATION; PARTICLE SIZE; PRIORITY JOURNAL; RAT; REPRODUCIBILITY; TEMPERATURE; ZETA POTENTIAL;

ACRYLIC RESINS; ANIMALS; CHEMISTRY, PHARMACEUTICAL; CHITIN; CYSTEINE; DRUG CARRIERS; FLAVIN MONONUCLEOTIDE; MALE; PERMEABILITY; RATS; STOMACH;

EID: 77952128924     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/10611860903483370     Document Type: Article

References (30)

1. Akiyama Y, Nagahara N, Nara E, Kitano M, Iwasa S, Yamamoto I, Azuma J, Ogawa Y. (1998). Evaluation of oral mucoadhesive microspheres in man on the basis of the pharmacokinetics of furosemide and riboflavin, compounds with limited gastrointestinal absorption sites. J Pharm Pharmacol, 50: 159-166.
2. Albrecht K, Zirm EJ, Palmberger TF, Schlocker W, Bernkop-Schnürch A. (2006). Preparation of thiomer microparticles and in vitro evaluation of parameters influencing their mucoadhesive properties. Drug Dev Ind Pharm, 32: 1149-1157.
3. Bernkop-Schnürch A, Greimel A. (2005). Thiomers: the next generation of mucoadhesive polymers. Am J Drug Deliv, 3: 141-154. (Pubitemid 43128326)
4. Bernkop-Schnürch A, Heinrich A, Greimel A. (2006). Development of a novel method for the preparation of submicron particles based on thiolated chitosan. Eur J Pharm Biopharm, 63: 166-172.
5. Bernkop-Schnürch A, Hornof M, Zoidl T. (2003a). Thiolated polymers-thiomers: synthesis and in vitro evaluation of chitosan-2-iminothiolane conjugates. Int J Pharm, 260: 229-237.
6. Bernkop-Schnürch A, Kast CE, Guggi D. (2003b). Permeation enhancing polymers in oral delivery of hydrophilic macromolecules: thiomer/ GSH systems. J Control Release, 93: 95-103.
7. Bernkop-Schnürch A, Pinter Y, Guggi D, Kahlbacher H, Schöffmann G, Schuh M, Schmerold I, Del Curto MD, D'Antonio M, Esposito P, Huck C. (2005). The use of thiolated polymers as carrier matrix in oral peptide delivery-proof of concept. J Control Release, 106: 26-33.
8. Bernkop-Schnürch A, Schwarz V, Steininger S. (1999). Polymers with thiol groups: a new generation of mucoadhesive polymers? Pharm Res, 16: 876-881. (Pubitemid 29284199)
9. Chun MK, Sah H, Choi HK. (2005). Preparation of mucoadhesive microspheres containing antimicrobial agents for eradication of H. pylori. Int J Pharm, 297: 172-179.
10. Clausen AE, Bernkop-Schnürch A. (2000). In vitro evaluation of the permeation-enhancing effect of thiolated polycarbophil. J Pharm Sci, 89: 1253-1261.
11. Clausen AE, Bernkop-Schnürch A. (2001). Thiolated carboxymethylcellulose: in vitro evaluation of its permeation enhancing effect on peptide drugs. Eur J Pharm Biopharm, 51: 25-32.
12. Clausen AE, Kast CE, Bernkop-Schnürch A. (2002). The role of glutathione in the permeation enhancing effect of thiolated polymers. Pharm Res, 19: 602-608.
13. Coupe AJ, Davis SS, Wilding IR. (1991). Variation in gastrointestinal transit of pharmaceutical dosage forms in healthy subjects. Pharm Res, 8: 360-364.
14. Deshpande AA, Rhodes CT, Shah NH, Malick AW. (1996). Controlledrelease drug delivery systems for prolonged gastric residence: an overview. Drug Dev Ind Pharm, 22: 531-539.
15. Greimel A, Werle M, Bernkop-Schnürch A. (2007). Oral peptide delivery: in-vitro evaluation of thiolated alginate/poly(acrylic acid) microparticles. J Pharm Pharmacol, 59: 1191-1198.
16. Guggi D, Marschütz MK, Bernkop-Schnürch A. (2004). Matrix tablets based on thiolated poly(acrylic acid): pH-dependent variation in disintegration and mucoadhesion. Int J Pharm, 274: 97-105.
17. Harris DH, Fell JT, Sharma HL, Taylor DC. (1990). GI transit of potential bioadhesive formulations in man: A scintigraphic study. J Control Release, 12: 45-53.
18. Hoyer H, Schlocker W, Krum K, Bernkop-Schnürch A. (2008). Preparation and evaluation of microparticles from thiolated polymers via air jet milling. Eur J Pharm Biopharm, 69: 476-485.
19. Imam ME, Bernkop-Schnürch A. (2005). Controlled drug delivery systems based on thiolated chitosan microspheres. Drug Dev Ind Pharm, 31: 557-565.
20. Jusko WJ, Levy G. (1967). Absorption, metabolism, and excretion of riboflavin-5β-phosphate in man. J Pharm Sci, 56: 58-62.
21. Kagan L, Lapidot N, Afargan M, Kirmayer D, Moor E, Mardor Y, Friedman M, Hoffman A. (2006). Gastroretentive Accordion Pill: Enhancement of riboflavin bioavailability in humans. J Control Release, 113: 208-215.
22. Kast CE, Guggi D, Langoth N, Bernkop-Schnürch A. (2003). Development and in vivo evaluation of an oral delivery system for low molecular weight heparin based on thiolated polycarbophil. Pharm Res, 20: 931-936.
23. Krauland AH, Bernkop-Schnürch A. (2004). Thiomers: development and in vitro evaluation of a peroral microparticulate peptide delivery system. Eur J Pharm Biopharm, 57: 181-187. (Pubitemid 38283693)
24. Leitner VM, Walker GF, Bernkop-Schnürch A. (2003). Thiolated polymers: evidence for the formation of disulphide bonds with mucus glycoproteins. Eur J Pharm Biopharm, 56: 207-214.
25. Luciano L, Reale E. (1992). The "limiting ridge" of the rat stomach. Arch Histol Cytol, 55 Suppl: 131-138.
26. Marschütz MK, Bernkop-Schnürch A. (2002). Thiolated polymers: self-crosslinking properties of thiolated 450 kDa poly(acrylic acid) and their influence on mucoadhesion. Eur J Pharm Sci, 15: 387-394.
27. Moës AJ. (1993). Gastroretentive dosage forms. Crit Rev Ther Drug Carrier Syst, 10: 143-195.
28. Roldo M, Hornof M, Caliceti P, Bernkop-Schnürch A. (2004). Mucoadhesive thiolated chitosans as platforms for oral controlled drug delivery: synthesis and in vitro evaluation. Eur J Pharm Biopharm, 57: 115-121. (Pubitemid 38058810)
29. Schlocker W, Gschliesser S, Bernkop-Schnürch A. (2006). Evaluation of the potential of air jet milling of solid protein-poly(acrylate) complexes for microparticle preparation. Eur J Pharm Biopharm, 62: 260-266.
30. Validation of analytical procedures, Proceedings of International Conference on Harmonisation (ICH). (1996). Commission of the European Communities.